Protective effects of vitamin D3 on the kidney of diabetic rats

Hui-min Li,Heng MIAO,Xiu-qin JIANG
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.03.057
2005-01-01
Abstract:Aim: To investigate the role and mechanism of vitamin D3 in protecting the renal lesion of diabetic rats. Methods: Thirty female SD rats(cleaning grade), 3 months old, were randomly divided into 3 groups with 10 rats in each group: normal control group, diabetic model group and vitamin D3 treated group. Blood glucose, glycated haemoglobin A1c(HbA1c), serum creatinine, blood uria nitrogen, urinary albumin, serum cholesterol, triglyceride(TG) and serum transforming growth factor-beta 1 (TGF-β1) levels were observed 4 and 8 weeks after treatment in all groups, the changes of TGF-β1 expression of renal cortex were measured by reverse transcription-polymerase chain reaction(RT-PCR) method, fibronectin(FN) and laminin(LN) expressions were detected with the immuneohistochemistry. Results: The urinary albumin excretion at 4 weeks in the vitamin D3 treated group[(10.28 ± 1.09) μg per 24 hours] was decreased as compared with that in the diabetic model group[(12.62 ± 0.51) μg per 24 hours] t = 3.987, P < 0.05), and that at the 8 weeks was also decrease (t = 4.475, P < 0.01). The serum TGF-β1 level at 8 weeks in the vitamin D3 treated group was reduced obviously as compared with that in the diabetic model group (t = 2.704, P < 0.05). The TGF-β 1 mRNA expression of renal cortex in the vitamin D3 treated group was significantly lower than that in the diabetic model group(t = 7.697, P < 0.01; t = 3.068, P < 0.05). The results of immunohistochemistry showed that there was an increase of FN and LN deposition in renal corpuscle of diabetic rats, and the FN and LN expressions in the vitamin D3 treated group were lower than those in the diabetic model group(t = -3.228, -1.432, P < 0.01). Conclusion: Vitamin D3 has some protective effects on renal lesion of diabetic rats, partly through decreasing the expression of TGF-β1 mRNA of renal cortex and serum TGF-β 1 level, thus reducing extracellular matrix proteins deposition in glomerular.
What problem does this paper attempt to address?